Search research articles
Contact Us
Filters
Showing results (81-90 of 108) with videos related to
Page
of 11
Sort By:
In Vivo (Athens, Greece)
|
April 29, 2021
Rare Nivolumab-associated Super Hyper Progressive Disease in Patients With Advanced Gastric Cancer
Yutaro Kubota, Kiyoshi Yoshimura, Kazuyuki Hamada, et al.
Cancer Research
|
January 21, 2006
Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes
Kiyoshi Yoshimura, Ajay Jain, Heather E Allen, et al.
Journal for Immunotherapy of Cancer
|
September 14, 2023
Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)
Jun Masuda, Hitomi Sakai, Junji Tsurutani, et al.
Anticancer Research
|
July 26, 2017
Correlation Between NKG2DL Expression and Antitumor Effect of Protein-bound Polysaccharide-K in Tumor-bearing Mouse Models
Ayano Konagai, Kiyoshi Yoshimura, Shouichi Hazama, et al.
Cancer Science
|
August 26, 2016
Calreticulin is highly expressed in pancreatic cancer stem-like cells
Satoshi Matsukuma, Kiyoshi Yoshimura, Tomio Ueno, et al.
Anticancer Research
|
October 1, 2021
Antibiotic Usage Reduced Overall Survival by over 70% in Non-small Cell Lung Cancer Patients on Anti-PD-1 Immunotherapy
Kazuyuki Hamada, Kiyoshi Yoshimura, Yuya Hirasawa, et al.
Oncology Letters
|
August 10, 2023
Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapy
Ryotaro Ohkuma, Yuki Fujimoto, Katsuaki Ieguchi, et al.
Oncology Letters
|
February 3, 2018
Expression levels of UL16 binding protein 1 and natural killer group 2 member D affect overall survival in patients with gastric cancer following gastrectomy
Ryoji Kamei, Kiyoshi Yoshimura, Shigefumi Yoshino, et al.
Frontiers in Immunology
|
September 24, 2025
Tumor <i>Akkermansia muciniphila</i> predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression
Takashi Shimizu, Ryotaro Ohkuma, Mayumi Homma, et al.
International Journal of Oncology
|
December 28, 2020
High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer
Ryotaro Ohkuma, Erica Yada, Shumpei Ishikawa, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 108) with videos related to
Sort By:
Page
of 11
In Vivo (Athens, Greece)
|
April 29, 2021
Rare Nivolumab-associated Super Hyper Progressive Disease in Patients With Advanced Gastric Cancer
Yutaro Kubota, Kiyoshi Yoshimura, Kazuyuki Hamada, et al.
Cancer Research
|
January 21, 2006
Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes
Kiyoshi Yoshimura, Ajay Jain, Heather E Allen, et al.
Journal for Immunotherapy of Cancer
|
September 14, 2023
Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)
Jun Masuda, Hitomi Sakai, Junji Tsurutani, et al.
Anticancer Research
|
July 26, 2017
Correlation Between NKG2DL Expression and Antitumor Effect of Protein-bound Polysaccharide-K in Tumor-bearing Mouse Models
Ayano Konagai, Kiyoshi Yoshimura, Shouichi Hazama, et al.
Cancer Science
|
August 26, 2016
Calreticulin is highly expressed in pancreatic cancer stem-like cells
Satoshi Matsukuma, Kiyoshi Yoshimura, Tomio Ueno, et al.
Anticancer Research
|
October 1, 2021
Antibiotic Usage Reduced Overall Survival by over 70% in Non-small Cell Lung Cancer Patients on Anti-PD-1 Immunotherapy
Kazuyuki Hamada, Kiyoshi Yoshimura, Yuya Hirasawa, et al.
Oncology Letters
|
August 10, 2023
Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapy
Ryotaro Ohkuma, Yuki Fujimoto, Katsuaki Ieguchi, et al.
Oncology Letters
|
February 3, 2018
Expression levels of UL16 binding protein 1 and natural killer group 2 member D affect overall survival in patients with gastric cancer following gastrectomy
Ryoji Kamei, Kiyoshi Yoshimura, Shigefumi Yoshino, et al.
Frontiers in Immunology
|
September 24, 2025
Tumor <i>Akkermansia muciniphila</i> predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression
Takashi Shimizu, Ryotaro Ohkuma, Mayumi Homma, et al.
International Journal of Oncology
|
December 28, 2020
High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer
Ryotaro Ohkuma, Erica Yada, Shumpei Ishikawa, et al.
Page
of 11